UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.604-612

2013

Volltextzugriff (PDF)

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.886-895

2018

Volltextzugriff (PDF)

High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2011-11, Vol.34 (10), p.1185-1192

2011

Volltextzugriff (PDF)

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1356-1362

1999

Volltextzugriff (PDF)

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1226-1227

2018

Volltextzugriff (PDF)

Recurrent Primary Biliary Cirrhosis After Liver Transplantation

American journal of transplantation, 2010-04, Vol.10 (4), p.720-726

2010

Volltextzugriff (PDF)

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Alimentary pharmacology & therapeutics, 2011-01, Vol.33 (2), p.235-242

2011

Volltextzugriff (PDF)

Bile acid changes after high‐dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

Hepatology (Baltimore, Md.), 2010-07, Vol.52 (1), p.197-203

2010

Volltextzugriff (PDF)

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

The American journal of gastroenterology, 1999-04, Vol.94 (4), p.1018-1022

1999

Volltextzugriff (PDF)

Ursodiol for Primary Sclerosing Cholangitis

The New England journal of medicine, 1997-03, Vol.336 (10), p.691-695

Lindor, Keith D

1997

Volltextzugriff (PDF)

Primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.325-332

1999

Volltextzugriff (PDF)

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

Gastroenterology (New York, N.Y. 1943), 1997-09, Vol.113 (3), p.884-890

1997

Volltextzugriff (PDF)

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (5), p.490-490

2015

Volltextzugriff (PDF)

Review article: Non-alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2003-04, Vol.17 (8), p.977-986

2003

Volltextzugriff (PDF)

Medical Treatments in Patients with Primary Sclerosing Cholangitis Differ between Europe and North America

Journal of hepatology, 2016, Vol.64 (2), p.S641-S641

2016

Volltextzugriff (PDF)

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (2), p.255-265

2012

Volltextzugriff (PDF)

A revised natural history model for primary sclerosing cholangitis

Mayo Clinic proceedings, 2000-07, Vol.75 (7), p.688-694

2000

Volltextzugriff (PDF)

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (7), p.886-894

2008

Volltextzugriff (PDF)

Non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2003-04, Vol.17 (8), p.977-986

2003

Volltextzugriff (PDF)

Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

Hepatology (Baltimore, Md.), 1996-06, Vol.23 (6), p.1464-1467

1996

Volltextzugriff (PDF)

Metabolic and Nutritional Considerations in Nonalcoholic Fatty Liver

Hepatology, 2000-07, Vol.32 (1), p.3-10

2000

Volltextzugriff (PDF)

Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’

Journal of Hepatology, 2001-07, Vol.35 (1), p.134-146

2001

Volltextzugriff (PDF)

Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies

Seminars in liver disease, 2001, Vol.21 (1), p.081-088

2001

Volltextzugriff (PDF)

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Hepatology (Baltimore, Md.), 2000-02, Vol.31 (2), p.318-323

2000

Volltextzugriff (PDF)

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.2711-2717

2001

Volltextzugriff (PDF)

1 – 25 von 520

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(496)
Mit Volltextzugriff
(408)

Publikationsform

Sprache

Englisch
(520)

Erscheinungsjahr

n.n

Thema

Science & Technology
(350)
Humans
(344)
Life Sciences & Biomedicine
(342)
Female
(226)
Gastroenterology & Hepatology
(218)
Male
(216)
Middle Aged
(200)
Biological And Medical Sciences
(196)
Medical Sciences
(195)
Adult
(179)
Aged
(131)
Gastroenterology. Liver. Pancreas. Abdomen
(116)
Other Diseases. Semiology
(87)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(84)
Ursodeoxycholic Acid - Therapeutic Use
(68)
Risk Factors
(67)
Liver Cirrhosis, Biliary - Drug Therapy
(57)
Digestive System
(52)
Colorectal Cancer
(51)
Colorectal Neoplasms - Genetics
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Recurrent Primary Biliary Cirrhosis After Liver Transplantation

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Bile acid changes after high‐dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

Ursodiol for Primary Sclerosing Cholangitis

Primary sclerosing cholangitis

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Review article: Non-alcoholic fatty liver disease

Medical Treatments in Patients with Primary Sclerosing Cholangitis Differ between Europe and North America

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

A revised natural history model for primary sclerosing cholangitis

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol

Non‐alcoholic fatty liver disease

Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

Metabolic and Nutritional Considerations in Nonalcoholic Fatty Liver

Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’

Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

Suchergebnisse filtern